Linked Life Data

7903370

Source:http://linkedlifedata.com/resource/pubmed/id/7903370

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7903370rdf:typepubmed:Citationlld:pubmed
pubmed-article:7903370lifeskim:mentionsumls-concept:C1176472lld:lifeskim
pubmed-article:7903370lifeskim:mentionsumls-concept:C0039067lld:lifeskim
pubmed-article:7903370lifeskim:mentionsumls-concept:C0028351lld:lifeskim
pubmed-article:7903370lifeskim:mentionsumls-concept:C1882598lld:lifeskim
pubmed-article:7903370lifeskim:mentionsumls-concept:C2003941lld:lifeskim
pubmed-article:7903370lifeskim:mentionsumls-concept:C0427574lld:lifeskim
pubmed-article:7903370lifeskim:mentionsumls-concept:C1709059lld:lifeskim
pubmed-article:7903370lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:7903370lifeskim:mentionsumls-concept:C0449560lld:lifeskim
pubmed-article:7903370lifeskim:mentionsumls-concept:C1314939lld:lifeskim
pubmed-article:7903370pubmed:issue9lld:pubmed
pubmed-article:7903370pubmed:dateCreated1994-1-24lld:pubmed
pubmed-article:7903370pubmed:abstractTextThree selective alpha 2A- or alpha 2B-adrenergic antagonists (BRL-44408, BRL-41992 and imiloxan) were used in the present study designed to classify the presynaptic alpha 2-auto- and heteroreceptors in the rat brain cortex. The rank order of potency in antagonizing the inhibitory effect of (-)-noradrenaline or clonidine on the K(+)-induced [3H]noradrenaline and [3H]5-hydroxytryptamine (5-HT) release from superfused synaptosomes was BRL-44408 > or = BRL-41992 >> imiloxan. The same rank order was found for the affinities of these compounds for [3H]yohimbine binding in human platelet membranes, containing only alpha 2A-adrenoceptors, but does not correlate with the known affinities for alpha 2B-adrenoceptors (BRL-41992 > or = imiloxan > BRL-44408). These data support the conclusion that presynaptic alpha 2-auto- and heteroreceptors in rat brain cortex do not belong to the alpha 2B-subtype and suggest that the modulation of noradrenaline and 5-HT release may be mediated by the alpha 2A-subtype.lld:pubmed
pubmed-article:7903370pubmed:languageenglld:pubmed
pubmed-article:7903370pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7903370pubmed:citationSubsetIMlld:pubmed
pubmed-article:7903370pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7903370pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7903370pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7903370pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7903370pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7903370pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7903370pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7903370pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7903370pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7903370pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7903370pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7903370pubmed:statusMEDLINElld:pubmed
pubmed-article:7903370pubmed:monthSeplld:pubmed
pubmed-article:7903370pubmed:issn0022-3573lld:pubmed
pubmed-article:7903370pubmed:authorpubmed-author:MenniniTTlld:pubmed
pubmed-article:7903370pubmed:authorpubmed-author:GobbiMMlld:pubmed
pubmed-article:7903370pubmed:authorpubmed-author:FrittoliEElld:pubmed
pubmed-article:7903370pubmed:issnTypePrintlld:pubmed
pubmed-article:7903370pubmed:volume45lld:pubmed
pubmed-article:7903370pubmed:ownerNLMlld:pubmed
pubmed-article:7903370pubmed:authorsCompleteYlld:pubmed
pubmed-article:7903370pubmed:pagination811-4lld:pubmed
pubmed-article:7903370pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:7903370pubmed:meshHeadingpubmed-meshheading:7903370-...lld:pubmed
pubmed-article:7903370pubmed:meshHeadingpubmed-meshheading:7903370-...lld:pubmed
pubmed-article:7903370pubmed:meshHeadingpubmed-meshheading:7903370-...lld:pubmed
pubmed-article:7903370pubmed:meshHeadingpubmed-meshheading:7903370-...lld:pubmed
pubmed-article:7903370pubmed:meshHeadingpubmed-meshheading:7903370-...lld:pubmed
pubmed-article:7903370pubmed:meshHeadingpubmed-meshheading:7903370-...lld:pubmed
pubmed-article:7903370pubmed:meshHeadingpubmed-meshheading:7903370-...lld:pubmed
pubmed-article:7903370pubmed:meshHeadingpubmed-meshheading:7903370-...lld:pubmed
pubmed-article:7903370pubmed:meshHeadingpubmed-meshheading:7903370-...lld:pubmed
pubmed-article:7903370pubmed:meshHeadingpubmed-meshheading:7903370-...lld:pubmed
pubmed-article:7903370pubmed:meshHeadingpubmed-meshheading:7903370-...lld:pubmed
pubmed-article:7903370pubmed:meshHeadingpubmed-meshheading:7903370-...lld:pubmed
pubmed-article:7903370pubmed:meshHeadingpubmed-meshheading:7903370-...lld:pubmed
pubmed-article:7903370pubmed:meshHeadingpubmed-meshheading:7903370-...lld:pubmed
pubmed-article:7903370pubmed:meshHeadingpubmed-meshheading:7903370-...lld:pubmed
pubmed-article:7903370pubmed:year1993lld:pubmed
pubmed-article:7903370pubmed:articleTitleFurther studies on alpha 2-adrenoceptor subtypes involved in the modulation of [3H]noradrenaline and [3H]5-hydroxytryptamine release from rat brain cortex synaptosomes.lld:pubmed
pubmed-article:7903370pubmed:affiliationIstituto di Richerche Farmacologiche Mario Negri, Milano, Italy.lld:pubmed
pubmed-article:7903370pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7903370pubmed:publicationTypeIn Vitrolld:pubmed
pubmed-article:7903370pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7903370lld:pubmed